Rubin Marc
SEC insider (Form 3/4/5 filer). CIK 0001412377. Director at CURIS INC (CRIS) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on Jul 7, 2026. Located in LEXINGTON, MA.
Companies Rubin Marc has filed insider reports for
- CURIS INC (CRIS): Director
- GALECTIN THERAPEUTICS INC (GALT): Director
Rubin Marc
CIK: 0001412377
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jul 7, 2026CRIS
CURIS INC
AwardDirectNon Qualified Stock Option
6.8K shares at avg. $5.29- - Mar 20, 2026CRIS
CURIS INC
ConversionDirect26.7K shares- - Mar 17, 2026CRIS
CURIS INC
AwardDirectSeries A Warrant (right to buy)
26.7K shares- - Mar 17, 2026CRIS
CURIS INC
AwardDirectSeries B Convertible Preferred Stock
20 shares- - Mar 17, 2026CRIS
CURIS INC
AwardDirectSeries B Warrant (right to buy)
26.7K shares- - Mar 17, 2026CRIS
CURIS INC
AwardDirectSeries C Warrant (right to buy)
26.7K shares- - May 20, 2025CRIS
CURIS INC
AwardDirectNon Qualified Stock Option
14.4K shares at avg. $3.13- - Jan 28, 2025CRIS
CURIS INC
AwardDirectNon Qualified Stock Option
1.6K shares at avg. $3.13- - Jan 23, 2025GALT
GALECTIN THERAPEUTICS INC
AwardDirectStock Option (right to buy)
60K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 7, 2026 |  CRIS CURIS INC | Award Non Qualified Stock Option | 6,800 | $5.29 | - | Direct |
| Mar 20, 2026 | CRIS CURIS INC | Conversion | 26,667 | - | $0 | Direct |
| Mar 17, 2026 | CRIS CURIS INC | Award Series A Warrant (right to buy) | 26,667 | - | - | Direct |
| Mar 17, 2026 | CRIS CURIS INC | Award Series B Convertible Preferred Stock | 20 | - | - | Direct |
| Mar 17, 2026 | CRIS CURIS INC | Award Series B Warrant (right to buy) | 26,667 | - | - | Direct |
| Mar 17, 2026 | CRIS CURIS INC | Award Series C Warrant (right to buy) | 26,667 | - | - | Direct |
| May 20, 2025 | CRIS CURIS INC | Award Non Qualified Stock Option | 14,400 | $3.13 | - | Direct |
| Jan 28, 2025 | CRIS CURIS INC | Award Non Qualified Stock Option | 1,600 | $3.13 | - | Direct |
| Jan 23, 2025 |  GALT GALECTIN THERAPEUTICS INC | Award Stock Option (right to buy) | 60,000 | - | - | Direct |
1-9 of 9 transactions